UIM6:XETRA:XETRA-UBS ETF SICAV - MSCI USA UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 494.04

Change

+0.71 (+0.14)%

Market Cap

USD 0.47B

Volume

24.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.10 (-0.19%)

USD 548.90B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.05 (-0.30%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.09%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.04 (-0.14%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.03 (+0.10%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

-2.02 (-1.32%)

USD 103.20B
JARI:XETRA Amundi Index Solutions - Amund..

-0.06 (-0.13%)

USD 102.92B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.12 (-0.23%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-2.52 (-0.46%)

USD 80.38B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.07 (-0.28%)

USD 79.79B

ETFs Containing UIM6:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 17.93% 87% B+ 86% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.93% 87% B+ 85% B
Trailing 12 Months  
Capital Gain 27.21% 84% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.21% 84% B 83% B
Trailing 5 Years  
Capital Gain 92.77% 94% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 92.77% 93% A 89% A-
Average Annual (5 Year Horizon)  
Capital Gain 13.92% 87% B+ 83% B
Dividend Return 14.09% 87% B+ 82% B
Total Return 0.17% 63% D 64% D
Risk Return Profile  
Volatility (Standard Deviation) 14.81% 38% F 49% F
Risk Adjusted Return 95.13% 96% N/A 96% N/A
Market Capitalization 0.47B 66% D+ 58% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.